Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AHPA

Avista Public Acquisitio... (AHPA)

Avista Public Acquisition Corporation II
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AHPA
DataHoraFonteTítuloCódigoCompanhia
27/06/202319:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AHPAAvista Public Acquisition Corporation II
26/06/202317:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AHPAAvista Public Acquisition Corporation II
18/05/202317:39Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AHPAAvista Public Acquisition Corporation II
11/05/202318:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AHPAAvista Public Acquisition Corporation II
11/05/202307:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AHPAAvista Public Acquisition Corporation II
05/05/202317:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AHPAAvista Public Acquisition Corporation II
01/05/202310:05Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:AHPAAvista Public Acquisition Corporation II
01/05/202310:03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AHPAAvista Public Acquisition Corporation II
01/05/202310:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AHPAAvista Public Acquisition Corporation II
31/03/202307:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AHPAAvista Public Acquisition Corporation II
08/03/202316:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
13/02/202314:29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AHPAAvista Public Acquisition Corporation II
07/02/202308:10Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
05/01/202319:08Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
03/01/202319:00Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AHPAAvista Public Acquisition Corporation II
30/11/202218:54Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:AHPAAvista Public Acquisition Corporation II
23/11/202211:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
14/11/202218:39Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:AHPAAvista Public Acquisition Corporation II
14/11/202218:09Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
10/11/202219:12Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AHPAAvista Public Acquisition Corporation II
01/11/202217:29Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AHPAAvista Public Acquisition Corporation II
01/11/202211:32Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:AHPAAvista Public Acquisition Corporation II
24/10/202218:00Business WireOmniAb Business Combination Approved by APAC ShareholdersNASDAQ:AHPAAvista Public Acquisition Corporation II
03/10/202209:24Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AHPAAvista Public Acquisition Corporation II
03/10/202209:00PR Newswire (US)Avista Public Acquisition Corp. II Announces Effectiveness of Registration Statement and Sets Date for Extraordinary General Meeting to Vote on Proposed Business CombinationNASDAQ:AHPAAvista Public Acquisition Corporation II
27/09/202218:02Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
24/08/202218:00Business WireLigand Announces that Janssen has Received Approval from European Commission for TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple MyelomaNASDAQ:AHPAAvista Public Acquisition Corporation II
08/08/202217:01Business WireLigand Reports Second Quarter 2022 Financial ResultsNASDAQ:AHPAAvista Public Acquisition Corporation II
16/05/202217:11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:AHPAAvista Public Acquisition Corporation II
04/05/202217:01Business WireLigand Reports First Quarter 2022 Financial ResultsNASDAQ:AHPAAvista Public Acquisition Corporation II
 Apresentando as notícias mais relevantes sobre:NASDAQ:AHPA